Athira Pharma, Inc.
ATHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$96,940 | -$117,672 | -$95,639 | -$54,853 |
| Dep. & Amort. | $455 | $969 | $1,048 | $479 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11,049 | $10,623 | $0 | $4,623 |
| Change in WC | -$11,982 | $6,527 | $11,938 | $6,005 |
| Other Non-Cash | $248 | -$1,200 | $10,184 | $648 |
| Operating Cash Flow | -$97,170 | -$100,753 | -$72,469 | -$43,098 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$33 | -$304 | -$1,141 | -$1,573 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14,134 | -$27,671 | -$95,288 | -$299,197 |
| Inv. Sales/Matur. | $68,997 | $123,064 | $154,093 | $296,691 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $54,830 | $95,089 | $57,664 | -$4,079 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $194 | $493 | $654 | $96,762 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $327 |
| Financing Cash Flow | $194 | $493 | $654 | $97,089 |
| Forex Effect | $0 | $0 | -$420 | $0 |
| Net Chg. in Cash | -$42,146 | -$5,171 | -$14,571 | $49,912 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $91,215 | $96,386 | $110,537 | $60,625 |
| End Cash | $49,069 | $91,215 | $95,966 | $110,537 |
| Free Cash Flow | -$97,203 | -$101,057 | -$73,610 | -$44,671 |